NEW YORK (GenomeWeb) – Recognizing the growing popularity of direct-to-consumer (DTC) genetic testing services like 23andMe, clinical labs are being asked to verify results that indicate individuals have an increased risk for diseases like cancer, and some commercial insurers are even paying for this confirmatory testing. A company called My Gene Counsel this week launched a pilot program that will provide education, facilitate genetic counseling, and if needed, offer confirmatory testing to individuals with a personal or family history of cancer who have taken a DTC cancer risk test but still have unanswered questions. My Gene Counsel is partnering with telegenetics firm GeneMatters to provide counseling and clinical testing lab Ambry Genetics for confirmatory testing.

To read the full article, click here.